— Know what they know.
/
Not Investment Advice

LIMN NASDAQ

Liminatus Pharma, Inc. Class A Common Stock
1W: -7.1% 1M: +1.6% 3M: -45.3% YTD: -87.8% 1Y: -95.5%
$3.90
+0.15 (+4.00%)
 
Weekly Expected Move ±10.0%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 38 · $5.2M mcap · 473594 float · 104.98% daily turnover · Short 30% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

ESG Scores — LIMN

Company vs Sector Average

Historical ESG Trend

View All ESG Filings (5)
Date Form Environmental Social Governance ESG Score Filing
2026-06-30 10-Q 30.5 67.8 70.5 56.3 SEC ↗
2026-03-31 10-Q 31.1 70.7 71.3 57.7 SEC ↗
2025-12-31 10-K 62.7 65.0 60.6 62.8 SEC ↗
2025-09-30 10-Q 31.1 66.2 71.2 56.1 SEC ↗
2025-06-30 10-Q 31.1 65.5 71.2 55.9 SEC ↗

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms